following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
., an emerita professor in the department of food science & technology at uc davis.
.
.
the uk�s initial plan had been challenged in court by the
.
.
.